DIN 02456869 — KEYTRUDA 25 MG
KEYTRUDA is a solution of Pembrolizumab marketed by MERCK CANADA INC. The full Pembrolizumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02456869
- Brand name
- KEYTRUDA
- Active ingredient
- Pembrolizumab
- Strength
- 25 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- MERCK CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Antineoplastic agent, PD-1 immune checkpoint inhibitor (monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Pembrolizumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02565382 | KEYTRUDA SC | 165 MG | SOLUTION | MERCK CANADA INC | MARKETED |